beta-thujaplicin has been researched along with hydroxychloroquine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, B; Hoang, BX | 1 |
1 other study(ies) available for beta-thujaplicin and hydroxychloroquine
| Article | Year |
|---|---|
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.
Topics: Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Homeostasis; Humans; Hydroxychloroquine; Ionophores; Models, Theoretical; Monoterpenes; Risk; Tropolone; Zinc | 2020 |